To clarify the underlying mechanism of HB-based immunomodulation, we analyzed mouse splenocytes in different treatment groups using multi-color flow cytometry to characterize the phenotype of CD4+ T cell subsets in DNCB-induced skin inflammation. The gene discussed is CD4; the disease is dermatitis.